Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
An announcement from Tsumura & Co ( (JP:4540) ) is now available.
Tsumura & Co. announced a revision to its performance-based stock compensation system for directors and executive officers, aligning it with their long-term vision ‘Cho-WA’ 2031. The revision aims to strengthen the link between executive compensation and corporate value, promoting sustainable growth and enhancing corporate value over the medium to long term. The changes, which include increasing the maximum contribution and the number of shares granted, are subject to shareholder approval.
More about Tsumura & Co
Tsumura & Co. operates in the pharmaceutical industry, focusing on the production and distribution of traditional Chinese herbal medicines. The company aims to enhance people’s well-being through its products and has a market focus on creating new markets and increasing happiness in anticipation of a long-term future.
YTD Price Performance: -6.24%
Average Trading Volume: 369,950
Technical Sentiment Signal: Buy
Current Market Cap: Yen332.6B
For a thorough assessment of 4540 stock, go to TipRanks’ Stock Analysis page.